We are live on ! Find out more
SONM icon

DNA X Inc
SONM

9 hedge funds and large institutions have $454K invested in DNA X Inc in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 9 → 9 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.46% less ownership

Funds ownership: 6.4% → 5.94% (-0.46%)

19% less capital inflows, than outflows

Capital inflows: $130K | Capital outflows: $160K

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CWM
C2C Wealth Management
Arizona
+$68.8K
2
Citadel Advisors
Citadel Advisors
Florida
+$56.5K
3
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
+$4.48K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$150K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$9.84K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$84
4
Danske Bank
Danske Bank
Denmark
-$16

SONM Hedge Fund Activity: Q2 2026 in Review

9 of the 8,355 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2026, worth a combined $454K — up 18% from $384K a quarter earlier.

Fund positioning in SONM was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was C2C Wealth Management, adding an estimated $68.8K. The largest seller was UBS Group, cutting an estimated $150K.

  • 9 institutional investors held DNA X Inc (SONM) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $454K of DNA X Inc stock for Q2 2026, up 18% quarter-over-quarter.
  • 1 fund opened new DNA X Inc positions in Q2 2026 and 1 closed out, a net change of 0 holders.
  • The largest DNA X Inc buyer in Q2 2026 was C2C Wealth Management, an estimated $68.8K added.
  • The largest DNA X Inc seller in Q2 2026 was UBS Group, an estimated $150K sold.

Based on aggregated 13F filings for Q2 2026.